[ad_1]
Charalambos Charilaou, a spokesman for public health services, told the CNA that the European Medicines Agency (EMA) would investigate the death.
The woman, who was being treated at a hospital in the capital Nicosia, received her first dose of AstraZeneca COVID-19 on May 6 in the resort town of Paphos.
An unidentified woman experienced side effects from the vaccine after a few days.
The Cypriot health services have launched an investigation into whether a “severe case of thrombosis” is related to the AstraZeneca vaccine.
Cyprus is also investigating four more “milder” blood clots in people vaccinated with AstraZeneca and Pfizer.
Due to the potential side effects of extremely rare blood clots, some countries have completely refused to vaccinate their populations with AstraZeneca, although the EVA says the benefits outweigh its risks.
AstraZeneca is a key vaccine in the Cyprus vaccination campaign, where GPs can vaccinate anyone over 20 years of age.
However, many people who sign up for the vaccine choose vaccines other than AstraZeneca.
According to the Our World in Data website, Cyprus ranks third in Europe in terms of vaccinations per 100 people. Here the figure is 57.54.
In Cyprus, almost 49% have received at least one dose of the vaccine so far. adult population, of which 21% fully vaccinated.
The total number of confirmed coronavirus cases in Cyprus since the start of the pandemic is 71,911, of which 354 have been fatal.
